Teva Pharmaceutical Industries Limited (TEV) — Cash Flow Quality Index
Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow Quality Index of -0.11x as of March 2026. Operating cash flow of €-40.00 Million is below net income of €369.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TEV strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Teva Pharmaceutical Industries Limited Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Teva Pharmaceutical Industries Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Teva Pharmaceutical Industries Limited tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year earnings quality comparison for Teva Pharmaceutical Industries Limited. For live market cap and the full company financial profile, see market value of Teva Pharmaceutical Industries Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | €1.65 Billion | €1.41 Billion | ▼ -38.9% |
| 2021 | 1.91x | €798.00 Million | €417.00 Million | ▼ -83.8% |
| 2016 | 11.82x | €3.89 Billion | €329.00 Million | ▲ +238.8% |
| 2015 | 3.49x | €5.54 Billion | €1.59 Billion | — |